The Venture Codex Logo

The Venture Codex

A1 Health Ventures

515 N. State Street, Suite 300, Chicago, IL, 60654, United States

Overview

A1 Health Ventures invests in transformational technology solutions that have been shown to improve healthcare organizations' operations and financial performance.A1 Health Ventures is a new venture capital firm founded by Abundant Venture Partners and First Trust Capital Partners.

Total investments
5
Lead investments
4
Investments · 12mo
1
Active investors
1
Visit website

Investment portfolio

  • Precise Behavioral

    Led · Equity · Jul 2026

    Founded in 2022 and based in Los Angeles, Precise Behavioral builds an integrated operating system that unifies clinical delivery, operational workflows and revenue cycle management for hospitals, health systems, ACOs, skilled nursing and correctional facilities. The company offers configurable modules including on-demand inpatient and ED consults, a virtual psychiatry and ambulatory clinic, a post-discharge ED follow-up solution (Precise ConnectED), and collaborative care services, each coupled with specialized revenue cycle and billing services. Precise reports more than 100,000 patient encounters and a national clinical footprint, and it reached profitability in under three years. Recent customer growth includes expanded partnerships with health systems such as CommonSpirit and Prime Healthcare. The company plans to use new funding to scale operations, grow its enterprise platform and advance AI-enabled patient engagement, referral management, virtual care operations and analytics.

  • hc1

    Participated · Equity · Jan 2025

    hc1 uses advanced data management, analytics, workflow automation and AI to turn diagnostic lab data into actionable insights that improve diagnoses and operational performance. The company completed an acquisition of healthcare performance consulting firm Accumen in October 2024 and markets the combined hc1 + Accumen platform. According to the release, thousands of health systems and labs leverage its technology and consultative services to care for nearly 100 million patients, and the company has over a decade of experience. The $6.25 million financing announced in January 2025 will support launching enhanced solutions that couple hc1 and Accumen’s technology and expertise. Product and operational priorities highlighted include lab stewardship, optimizing blood management and anemia care, eliminating supply chain waste, and improving lab outreach to drive profitable growth for health systems. The company positions these initiatives as advancing predictive insights, personalized care, and increased efficiencies across the care continuum. hc1.com provides a HIPAA-compliant healthcare CRM and analytics platform certified as an AWS Healthcare Competency solution. Its platform has been adopted across more than 1,200 lab, post-acute care, and provider locations and has organized over 5.2 billion clinical transactions into 52 million unique anonymous consumer profiles. The company offers information services including hc1 ProviderView™ and the hc1 Opioid Dashboard to drive personalized, high-value care and provider engagement. hc1 has been recognized as a top-rated healthcare CRM by Frost & Sullivan and counts organizations such as Cleveland Clinic and Nationwide Children’s Hospital among users. The company plans to accelerate development of its healthcare relationship management solutions, expand its team, and increase adoption of its information services. HC1 provides a scalable, cloud-based platform that ingests clinical and business data to help labs, pharmacies, physicians and health systems track business relationships and improve patient engagement. Its product is used to prompt follow-up actions (for example, identifying why a patient missed an appointment) and to coordinate multiparty communication across care teams. The company sees large near-term opportunities in diagnostics and potential future uses including aiding therapeutic discovery and identifying specimen errors. HC1 partners with technology providers such as IBM Watson to generate patient insights and reduce administrative burden through AI-powered tools. Its business model charges customers based on usage, and management plans to expand direct sales and strategic partnerships while adding sales and marketing staff. Financially, HC1 recently raised capital and credit to support this growth push, including a $13.2M financing and a $5M revolving credit facility.

  • Pip Care

    Led · Series A · Oct 2024

    Pip Care pairs a consumer‑friendly mobile app with one‑on‑one telehealth health coaches to deliver evidence‑based perioperative and post‑operative protocols and care coordination for surgical patients. The platform digitalizes protocols like Enhanced Recovery After Surgery (ERAS), tracks adherence, and supports surgeon‑ and surgery‑specific instructions to improve outcomes and reduce complications. Academic research cited by the company reports nearly a day shorter hospital stay for users and roughly half the risk of readmission within a week of surgery; Pip Care also reports moving more than 20 patient touch points to the platform and saving over 10 hours of front‑office time per patient. Launched in 2022 out of a collaboration between Redesign Health and UPMC Enterprises, Pip Care has early investments from those partners. The company recently secured a $2.2M NIH grant to launch a trial of its platform with 2,000 patients and says the new capital will fund its next phase of growth and deployment to health systems and surgical teams. Current funding sources include equity and grant support detailed in company disclosures.

  • Livara Health

    Led · Series B · May 2024

    Livara Health provides a value-based MSK management solution that combines care planning, virtual-first care delivery, and care navigation. The company uses a biopsychosocial approach across virtual and in-person pathways and reports fewer surgeries, injections, and opioid use versus traditional conservative treatment. Livara has treated over 120,000 people and entered 2024 with nearly 4 million people eligible to access its MSK platform via health plan and provider partnerships, including Medicare and commercial populations. It partners with payors and providers under flexible value-based payment arrangements and can assume the total cost of musculoskeletal care for partners. The new funding will accelerate innovation of Livara’s technology and clinical capabilities to expand its proprietary care delivery model and manage additional risk for partners. Formerly SpineZone and operating for over 17 years, Livara aims to grow all populations served and broaden its clinical programs. SpineZone delivers personalized exercise curricula for neck and back pain through a virtual physical-therapy platform augmented by in-person clinics. Patients answer intake questions via smartphone or laptop and then follow evidence-based exercise videos created with healthcare professionals. The in-person clinics provide hands-on support and help translate a video repository with tracked outcomes into real-world care. The company reports "1 million lives under management" and cites partner results such as a 50% reduction in surgery rate and Sharp Community Medical Group saving $3.4 million over two years. Its business model charges clinics based on members served per month and incorporates shared-upside/shared-downside agreements tied to cost outcomes. SpineZone positions itself against other musculoskeletal digital health startups and is pushing toward greater adoption of value-based care, projecting value-based revenue to reach about 50% in the near future.

  • Prolucent Health

    Led · Equity · Oct 2023

    Prolucent builds an AI-powered workforce management platform that unifies staffing across permanent, part-time, per diem, and travel staff. Its LiquidCompass VMS+ platform offers vendor-neutral management of staffing orders, fulfillment, credentialing, invoicing and advanced analytics. The platform includes a talent marketplace, digital front door, and real-time workforce intelligence tools to help health systems reduce labor costs and improve operational efficiency. Prolucent’s technology is integrated with Northwell Health’s FlexStaff internal staffing agency and external contract agencies. The platform is currently deployed across Northwell’s 21 hospitals in the greater New York metro area and beyond. Prolucent plans to use the strategic investment to accelerate development and expand its AI-driven workforce management solutions to healthcare organizations nationwide. Prolucent develops enterprise-wide healthcare workforce optimization software and services, centered on its Liquid Compass workforce management platform. The AI-driven Liquid Compass integrates a talent marketplace, advanced analytics, and a vendor-neutral VMS to centralize management of core staff, flexible staff, and external contingent staff. The platform aims to improve recruitment, utilization, and labor cost management to create sustainable labor cost savings for healthcare providers. With labor expenses accounting for more than 50 percent of hospitals' total expenses, Prolucent positions its solutions as a means to improve operating margins and workforce balance. The company said the new capital will fuel continued product innovation and support nationwide expansion as it embarks on its next phase of growth. Prolucent is based in Dallas. Prolucent Health offers end-to-end workforce optimization solutions for healthcare organizations, powered by its talent engagement platform Liquid Compass®. The platform uses technology, artificial intelligence, and advanced analytics to modernize recruitment, utilization, and labor cost management. For employers, Prolucent drives greater applicant volume and conversion, manages contingent labor and internal flexible labor pools, and provides real-time data on utilization and costs. For healthcare workers, the company operates an integrated jobs marketplace with tools to manage careers and simplify applications. Prolucent annually promotes more than four million open positions from 30,000 healthcare employers and has over 500,000 clinicians registered on the Liquid Compass platform. The company plans to expand its sales, marketing, and client services teams and broaden product capabilities using the new capital.

Team